Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights

Contributed by: Business Wire

Logo

Tags

Research

FDA

Clinical Trials

Cardiology

Biotechnology

Health

Pharmaceutical

Science

Oncology

Q4 FY2023

More Like This

Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights

Prothena Reports First Quarter 2024 Financial Results and Business Highlights

Prothena Reports Third Quarter 2023 Financial Results and Business Highlights

Prothena Reports Second Quarter 2024 Financial Results and Business Highlights

Prothena Reports Third Quarter 2024 Financial Results and Business Highlights

Prothena Reports First Quarter 2025 Financial Results and Business Highlights

Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024

Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs